Literature DB >> 20920194

Cytotoxic activity of Thai medicinal plants against human cholangiocarcinoma, laryngeal and hepatocarcinoma cells in vitro.

Wiratchanee Mahavorasirikul1, Vithoon Viyanant, Wanna Chaijaroenkul, Arunporn Itharat, Kesara Na-Bangchang.   

Abstract

BACKGROUND: Cholangiocarcinoma is a serious public health in Thailand with increasing incidence and mortality rates. The present study aimed to investigate cytotoxic activities of crude ethanol extracts of a total of 28 plants and 5 recipes used in Thai folklore medicine against human cholangiocarcinoma (CL-6), human laryngeal (Hep-2), and human hepatocarcinoma (HepG2) cell lines in vitro.
METHODS: Cytotoxic activity of the plant extracts against the cancerous cell lines compared with normal cell line (renal epithelial cell: HRE) were assessed using MTT assay. 5-fluorouracil was used as a positive control. The IC50 (concentration that inhibits cell growth by 50%) and the selectivity index (SI) were calculated.
RESULTS: The extracts from seven plant species (Atractylodes lancea, Kaempferia galangal, Zingiber officinal, Piper chaba, Mesua ferrea, Ligusticum sinense, Mimusops elengi) and one folklore recipe (Pra-Sa-Prao-Yhai) exhibited promising activity against the cholangiocarcinoma CL-6 cell line with survival of less than 50% at the concentration of 50 μg/ml. Among these, the extracts from the five plants and one recipe (Atractylodes lancea, Kaempferia galangal, Zingiber officinal, Piper chaba, Mesua ferrea, and Pra-Sa-Prao-Yhai recipe) showed potent cytotoxic activity with mean IC50 values of 24.09, 37.36, 34.26, 40.74, 48.23 and 44.12 μg/ml, respectively. All possessed high activity against Hep-2 cell with mean IC50 ranging from 18.93 to 32.40 μg/ml. In contrast, activity against the hepatoma cell HepG2 varied markedly; mean IC50 ranged from 9.67 to 115.47 μg/ml. The only promising extract was from Zingiber officinal (IC50=9.67 μg/ml). The sensitivity of all the four cells to 5-FU also varied according to cell types, particularly with CL-6 cell (IC50=757 micromolar). The extract from Atractylodes lancea appears to be both the most potent and most selective against cholangiocarcinoma (IC50=24.09 μg/ml, SI = 8.6).
CONCLUSIONS: The ethanolic extracts from five plants and one folklore recipe showed potent cytotoxic activity against CL-6 cell. Sensitivity to other cancerous cell lines varied according to cell types and the hepatocarcinoma cell line. HepG2 appears to be the most resistant to the tested extracts.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20920194      PMCID: PMC2956707          DOI: 10.1186/1472-6882-10-55

Source DB:  PubMed          Journal:  BMC Complement Altern Med        ISSN: 1472-6882            Impact factor:   3.659


Background

Cholangiocarcinoma, malignant epithelial cells that arises within bile duct, is a serious public health in Thailand with increasing incidence and mortality. The cancer occurs at a particularly high rate in Northeastern Thailand, with age-standardized incidence rate (ASRs) 33.4 per 100,000 in males and 12.3 per 100,000 in females [1]. It accounts for approximately 15% of liver cancer worldwide [2]. This cancer can be classified into three major groups, i.e., intrahepatic, perihilar and distal extrahepatic cholangiocarcinoma. Intrahepatic type is the most common case of cholangiocarcinoma in Thailand and infestation of Opisthorchis viverrini has been classified as a definite risk factor of the disease [3]. The lack of early detection and limited therapeutic options are major problems for controlling this type of cancer. At present, surgical resection of detectable tumors leads to an improvement in the 5-year survival rate. Adjunctive therapy with chemotherapeutic agents has been shown to improve local control, provide palliation, and prolong survival [4]. Even those with operable tumor, the recurrence rate is extremely high, with a 5-year survival rate of less than 40% [5,6]. Chemotherapeutic treatment of cholangiocarcinoma is largely ineffective; the standard chemotherapeutic agent, 5-fluorouracil (5-FU) always produces low clinical response rate [6-8]. Advanced surgical techniques in conjunction with alternative chemotherapeutic option with promising activity are required to improve the survival of patients. Cholangiocarcinoma is considered to be a multidrug and radio-resistant tumor and still require new approach of treatments [9]. Numerous cancer research for chemotherapeutic potential of medicinal plants have been carried out in an effort to discover new therapeutic agents that lack the toxic effects associated with current therapeutic agents. Traditional medicine is commonly used as an alternative treatment for cancer by Thai people [10]. Several Thai traditional folklores have been shown to possess anticancer activities in various human cancerous cell lines with some promising candidates [11,12]. In the present study, the ethanolic extracts of a total of 28 plants and 5 recipes used in Thai folklore medicine were investigated for their cytotoxic activity in vitro against three human cancerous cell lines, i.e., CL-6 (cholangiocarcinoma), Hep-2 (laryngeal carcinoma), HepG2 (hepatocarcinoma), and HRE (renal epithelial cells). To our knowledge, this is the first study that focused on the investigation of cytotoxic activity of Thai folklore against cholangiocarcinoma.

Methods

Reagents

Commercial grade ethanol was purchased from Labscan Co. Ltd. The cell culture medium and reagents were purchased from different sources: Ham-12, RPMI 1640, M-199 medium, from Gibco BRL Life Technologies (Grand Island, NY, USA), renal epithelium cell growth medium and SupplementPack from Promacell Co. Ltd. (Germany). Fetal bovine serum (FBS), L-glutamine dimethylsulfoxide (DMSO), the antibiotic solution, streptomycin-penicillin and antibiotic-antimycotic, were purchased from Gibco BRL Life Technologies. The reference compound, 5-fluorouracil (5-FU) and MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] were purchased from Sigma-Aldrich Inc. (St. Louis, MO, USA).

Plant materials and preparation of crude extracts

Plant materials were collected from various parts of Thailand and some were purchased from the city markets. Authentication of plant materials was carried out at the herbarium of the Department of Forestry, Bangkok, Thailand, where the herbarium vouchers have been kept. A duplicate set has been deposited in the herbarium of Southern Center of Thai Medicinal Plants at the Faculty of Pharmaceutical Science, Prince of Songkhla University, Songkhla, Thailand. The plant materials were rinsed thoroughly with tap water to remove extraneous contaminants and cut into small pieces, oven-dried at 50°C until stability of dry weight was observed, and then ground into powder with an electric-grinder. Extraction was carried out by macerating the powdered plant materials (100 g) in stoppered flasks containing 500 ml of 95% ethanol at room temperature (25-30°C) for 7 days. The extracted solvent was separated and filtered through Whatman no. 1 filter paper. After filtration, the extracts were evaporated under reduced pressure by rotary evaporation. The crude extracts were weighed and stored at −20°C until used.

Preparation of test materials and reference drug

The crude extract from each medicinal plant/recipe was initially dissolved in 50% ethanol. Concentrated stock solution of each extract was prepared by adding a known weight of each crude extract to a known volume of 50% ethanol, and then serially diluted (1:2) with complete media to obtain the working solutions at eight final concentrations. Positive control agent 5-FU was prepared similarly as the crude extract by dissolving in 50% ethanol.

In vitro assay for cytotoxic activity

Human cell lines and cell culture

The cholangiocarcinoma cell line CL-6, human laryngeal carcinoma cell line Hep-2, human hepatocarcinoma cell line HepG2 and normal human epithelial cell (HRE) were used for cytotoxic screening of the medicinal plant extracts. CL-6 cell line was established and kindly provided by Associate Professor Dr. Adisak Wongkajornsilp, Department of Pharmacology, Faculty of Medicine (Siriraj Hospital), Mahidol University, and were cultured in Ham-12 medium supplemented with 10% heated fetal bovine serum and 100 IU/ml of antibiotic-antimycotic solution. Hep-2 cell line was obtained from Department of Medical Technology, Faculty of Allied Health Sciences, Thammasat University, established and cultured in M-199 medium supplemented with 10% heated fetal bovine serum, 2.5 mM HEPES (pH 7.4) and 100 IU/ml penicillin-streptomycin solution. HepG2 cell line was purchased from the Cell Line Service Co. Ltd. (Germany) and was cultured in DMEM: Ham's F12 medium supplemented with 2 mM L-glutamine, 10% fetal bovine serum and 100 IU/ml pen-strep. Normal human renal epithelial cell line (HRE) was purchased from Promocell Co. Ltd. (Germany) and cultured in renal epithelial cell growth medium 2 with SupplementPack. All cells were maintained at 37°C in a 5% CO2 atmosphere with 95% humidity.

Cytotoxic assay

The MTT colorimetric assay developed by Mosmann [13] with modification was used to screen for cytotoxic activity of all the plant extracts. Briefly, the cells were seeded in 96-well plates at a density of 104 cells/well in 100 μl culture medium. Following 24-h incubation and attachment, the cells were treated with different concentrations of plant extracts and 5-FU (positive control) for 24 h. Each extract was screened initially for its cytotoxicity against all cancerous and normal cell lines at the concentration of 50 μg/ml. The potential candidates which resulted in cell survival of less than 50% were further assessed for their IC50 (concentration that inhibits cell growth by 50%) values at the concentration range of 250 and 1.95 μg/ml. The concentration range used for 5-FU was 78.13 to 10,000 μM. Following washing and incubation with MTT solution (20 μl of 5 mg/ml) at 37°C for 3 h, cells were lyzed with DMSO. The yellow MTT dye was reduced by succinic dehydrogenase in the mitochondria of viable cells to purple formazan crystals. Absorbance (OD) was measured at 570 nm using a microplate reader (Varioscan Flash, Thermo, Finland). The percentage of cytotoxicity compared to the untreated cells was determined with the equation: The results were generated from three independent experiments; each experiment was performed in triplicate. The IC50 values were calculated using CalcySyn™ (USA) software. The selectivity index (SI) was also calculated from the IC50 ratio of normal epithelial and cancerous (CL-6, Hep-2, HepG2) cells. SI value indicates selectivity of the sample to the cell lines tested. Samples with SI value greater than 3 were considered to have high selectivity.

Results and Discussion

Plants are promising source of anti-infective and anticancer chemotherapeutic agents. Saetung and colleague selected twelve Thai medicinal plants as the ingredients of a Southern Thai traditional folklore medicine for cancer treatment to test for their cytotoxicity activity against human lung and prostate cancer cell lines. The ethanolic extracts of the six plants (Bridelia ovata, Curcuma zedoaria, Derris scandens, Dioscorea membranacea, Nardostachys jatamansi and Rhinacanthus nasutus) showed promising cytotoxic activity (IC50 < 30 μg/ml) [14]. In the present study, the cytotoxic effect of a total of 28 ethanolic extracts of plants and 5 recipes from traditional folklore medicine against the human cholangiocarcinoma cell line CL-6 were investigated. In addition, their comparative activity against the other two human cancerous cell lines, i.e., Hep-2 (laryngeal carcinoma) and HepG2 (hepatocarcinoma), and one normal cell HRE (human renal epithelial cell) was also examined. These plants have been used by Thai people to treat different illness. The five recipes were used for restorativeness, treatment of fever, cold and cancer (Table 1). The eighteen plants tested were composition of Pra-Sa-Prao-Yhai recipe, and some plants were composition of other recipes (Table 1). The leave, stem, bark and rhizome parts of plants were most often used for these traditional medicines (Table 1). Results from the initial screening showed that the extracts from seven plant species (Atractylodes lancea, Kaempferia galangal, Zingiber officinal, Piper chaba, Mesua ferrea, Ligusticum sinense, Mimusops elengi) and one folklore recipe (Pra-Sa-Prao-Yhai) exhibited promising activity against the cholangiocarcinoma CL-6 cell line with cell survival of less than 50% at the concentration of 50 μg/ml (Table 2). Among these, six (Atractylodes lancea, Kaempferia galangal, Zingiber officinal, Piper chaba, Mesua ferrea, and Pra-Sa-Prao-Yhai recipe) showed potent cytotoxic activity with IC50 values of less than 50 μg/ml. The potency of the extracts in descending order was as follow: Atractylodes lancea, Zingiber officinal, Kaempferia galangal, Piper chaba, Pra-Sa-Prao-Yhai recipe and Mesua ferrea (Table 3). The plants Atractylodes lancea, Kaempferia galangal and Mesua ferrea are also composition of Pra-Sa-Prao-Yhai recipe. In the US National Cancer Institute Plant Screening Program, a crude extract is generally considered to have in vitro cytotoxic activity if the IC50 value in carcinoma cells, following incubation between 48 and 72 hours, is less than 20 μg/ml, while it is less than 4 μg/ml for pure compounds [15]. Based on this criteria, only the extract from Atractylodes lancea is considered highly active with IC50 of 24.04 ± 3.40 (mean ± SD) μg/ml. The extract from Dioscorea membranacea showed only weak activity in the screening test against cholangiocarcinoma cell. In our previous study [11], water extract of this plant (DM1 and DM2) exhibited promising cytotoxic activity against human breast adenocarcinoma MCF-7 (IC50 = 7.7 μg/ml) but only showed moderate activity against human large cell lung carcinoma COR-L23 (IC50 = 37.6 μg/ml) and human colon adenocarcinoma LS-174T (IC50 = 78.4 μg/ml) cell lines [16].
Table 1

The plant species and recipes used in Thai traditional folklore which were investigated for cytotoxicity

FamilyPlantPart usedVoucher specimenThai traditional Use
CompositaeArtemisia annua L.1RhSKP 051010101Treatment of fever, hemorrhoids [31]
CompositaeAtractylodes lancea (thung.) DC.1RhSKP 051011201Treatment of fever, colds, flu, sore throat [31]
CruciferaeAsclepias curassavica L.1,4FlSKP 057121901Used as analgesic [32]
DioscoreaceaeDioscorea membranaceaRhSKP 062041305Treatment of cancer [16]
DracaenaceaeDracaena loureiri Gagnep.1St, BaSKP 065041201Treatment of cough, fever, inflammation [32]
GuttiferaeMammea siamensis Kosterm1FlSKP 083131901Restorative [31]
GuttiferaeMesua ferrea L1FlSKP 083130601Treatment of dyspepsia [31]
MyristicaceaeMyristica fragrans Houtt.1SdSKP 121130601Treatment of uterus pain, diarrhea [33]
MyrtaceaeSyzygium aromaticum (L.) Merr. & L.M. Perry1FlSKP 123190101Treatment of toothache, bacterial infection [32]
NelumbonaceaeNigella sativa Linn.1,4SdSKP 160141901Treatment of jaundice [32]
PiperaceaePiper chaba Linn2,3FrSKP 146160301Used as carminative, antidiarrheal [31]
PiperaceaePiper interruptum Opiz. 2,3LfSKP 146160901Treatment of choke [31]
PiperaceaePiper sarmentosum Roxb.2,3RtSKP 146161901Treatment of fever, toothache, cough, asthma [31]
PlumbaginaceaePlumbago indica Linn.2,3RtSKP 148160901Treatment of rheumatism [32]
SmilacaceaeSmilax corbularia KunthRhSKP 179190315Treatment of cancer [16]
SapotadeaeMimusops elengi L.1FlSKP 171130501Used as cordial, tonic. Treatment of syncope [32]
UmbelliferaeAngelica dahurica Benth.1RtSKP 199010401Used as antipyretic, antiasthma, anticough [33]
UmbelliferaeAngelica sinensis (Oliv.) Diels1RhSKP 199010901Treatment of bronchitis pleurisy [33]
UmbelliferaeAnethum graveolens L.1,4Rt, FrSKP 199010701Used as carminative. Treatment of eye pain [32]
UmbelliferaeCuminum cyminum Linn.1,4SdSKP 199030301Treatment of dyspepsia, diarrhoea and jaundice [31]
UmbelliferaeFoeniculum vulgare Mill. var. dulce Alef.1,4SdSKP 199062201Used as analeptic [33]
UmbelliferaeLigusticum sinense Oliv. cv. Chuanxiong1RhSKP 199121901Treatment of urinary bladder channel, headache, neurodermatitis [32]
ZingiberaceaeAmomum testaceum Ridl.1SdSKP 206011101Used as carminative, antibacterial [33]
ZingiberaceaeCurcuma longa Linn.RhSKP 206012101Treatment of cancer, high cholesterol, dyspepsia, gallstone [33]
ZingiberaceaeKaempferia galangal1LfSKP 206110701Antinociceptive, anti-inflammatory [33]
ZingiberaceaeZingiber officinale Roscoe.2RhSKP 206261501Treatment of hypercholesteremia and high level triglyceride [33]
ZingiberaceaeZingiber ligulatum Roxb.3RhSKP 206261201Used as anti-inflammatory [33]
-Dioscorea membranacea &Smilax corbularia--Treatment of cancer [16]
-Ben-ja-Kul 1 Recipe--Used as restorative [31]
-Ben-ja-Kul 2 Recipe--Treatment of fever, cold [31]
-Pra-Sa-Prao-Yhai Recipe--Used as restorative, anti-emetic, setting up proper digestive system, analeptic [31]
-Tein-5 Recipe--Used as restorative, carminative [31]

Plant parts: Fr: Fruits, Fl: Flower, Lf: leaves, Rt: Root, Rh: Rhizomes, Sd: Seed, St: Stem.1Composition in Pra-Sa-Prao-Yhai Recipe, 2Composition in Ben-ja-Kul 1 Recipe, 3Composition in Ben-ja-Kul 2 Recipe, 4Composition in Tein-5 Recipe

Table 2

Percentage survival of cancer cell lines (CL-6, HepG2, Hep-2) treated with ethanolic extract from a total of 28 plants and 5 recipes used in Thai folklore medicine at the concentration of 50 μg/ml

PlantCell line
CL-6HepG2Hep-2
Atractylodes lancea32.10 ± 3.7293.80 ± 8.09-1.38 ± 0.67
Mesua ferrea35.67 ± 8.6664.62 ± 2.9212.55 ± 6.03
Kaempferia galangal (leaf)36.74 ± 11.7275.03 ± 17.785.65 ± 0.08
Ligusticum sinense Oliv43.85 ± 6.7369.74 ± 4.4636.81 ± 15.56
Zingiber officinal44.26 ± 8.9380.65 ± 11.928.11 ± 10.97
Artemisia annua46.56 ± 6.0395.76 ± 11.3533.48 ± 7.85
Kaempferia galangal (flower)47.49 ± 5.9569.36 ± 16.129.74 ± 0.07
Mimusops elengi48.84 ± 0.62109.99 ± 2.9554.44 ± 3.24
Pra-Sa-Prao-Yhai Recipe49.43 ± 8.7579.55 ± 23.9025.55 ± 5.32
Piper chaba50.62 ± 3.1072.25 ± 1.1512.42 ± 7.99
Mammea siamensis51.35 ± 3.8929.17 ± 12.2859.52 ± 44.80
Angelica sinensis51.77 ± 7.5381.94 ± 12.4833.77 ± 9.19
Syzygium aromaticum55.40 ± 0.5172.51 ± 15.3234.30 ± 21.33
Nigella sativa58.02 ± 2.25118.49 ± 6.3343.68 ± 0.49
Curcuma longa59.86 ± 6.4913.87 ± 12.880.57 ± 0.80
Ben-ja-Kul 1 Recipe61.33 ± 2.8487.19 ± 6.9833.12 ± 9.68
Foeniculum vulgare61.62 ± 8.8683.26 ± 4.7850.55 ± 11.04
Anethum graveolens63.28 ± 12.9297.47 ± 7.4055.11 ± 4.37
Ben-ja-Kul 2 Recipe63.78 ± 5.1593.02 ± 9.1546.27 ± 4.00
Piper pendulispicum64.94 ± 5.7862.66 ± 16.2825.60 ± 14.67
Myristica fragrans66.11 ± 2.1189.14 ± 20.9733.00 ± 13.32
Piper sarmentosum69.20 ± 4.3981.95 ± 10.7934.09 ± 8.96
Amomum testaceum72.30 ± 11.2490.74 ± 12.4771.24 ± 2.10
Cuminum cyminum74.07 ± 6.3887.25 ± 19.0639.28 ± 7.50
Zingiber ligulatum74.68 ± 2.17106.55 ± 14.2344.14 ± 2.28
Dioscorea membranacea76.05 ± 2.5790.86 ± 16.6559.90 ± 29.93
Plumbago indica77.79 ± 14.3161.83 ± 20.4540.50 ± 13.52
Tein-5 Recipe79.73 ± 2.5689.61 ± 16.6063.21 ± 3.74
Dracaena loureiri81.29 ± 10.4296.18 ± 5.8120.97 ± 28.05
Asclepias curassavica81.63 ± 3.9987.47 ± 13.6747.45 ± 5.01
Smilax corbularia81.77 ± 9.61147.02 ± 18.3968.96 ± 13.38
Dioscorea membranacea &Smilax corbularia82.31 ± 0.39141.96 ± 14.6476.64 ± 13.42
Angelica dahurica85.16 ± 5.5580.18 ± 13.4148.68 ± 2.68

Data are presented as mean ± SD from 3 independent experiments, triplicate for each)

Table 3

Cytotoxicity of 5-FU and ethanolic extracts from 5 medicinal plants and one recipe with promising activity

PlantsCell line
CL-6HepG2Hep-2HRE
IC50SIIC50SIIC50SIIC50
Atractylodes lancea24.09 ± 3.408.676.68 ± 15.942.729.35 ± 8.667.1207.59 ± 7.97
Kaempferia galangal (leaf)37.36 ± 3.982.9115.47 ± 26.230.918.99 ± 10.335.7119.20 ± 14.91
Zingiber officinal34.26 ± 7.653.59.67 ± 3.9112.632.40 ± 6.703.8121.50 ± 5.20
Piper chaba40.74 ± 5.304.568.09 ± 22.582.718.93 ± 5.039.8119.14 ± 9.94
Pra-Sa-Prao-Yhai recipe44.12 ± 11.585.9125.07 ± 3.082.1120.99 ± 2.6812.5263.51 ± 29.06
Mesua ferrea48.23 ± 5.842.586.47 ± 4.381.419.22 ± 5.316.3121.77 ± 29.08
5-FU (μM)757.00 ± 77.162.0633.08 ± 284.252.4141.49 ± 17.1410.81542.20 ± 1529.11

Data are presented otherwise specified as mean ± SD of IC50 (μg/ml) from 3 independent experiments, triplicate for each.

The plant species and recipes used in Thai traditional folklore which were investigated for cytotoxicity Plant parts: Fr: Fruits, Fl: Flower, Lf: leaves, Rt: Root, Rh: Rhizomes, Sd: Seed, St: Stem.1Composition in Pra-Sa-Prao-Yhai Recipe, 2Composition in Ben-ja-Kul 1 Recipe, 3Composition in Ben-ja-Kul 2 Recipe, 4Composition in Tein-5 Recipe Percentage survival of cancer cell lines (CL-6, HepG2, Hep-2) treated with ethanolic extract from a total of 28 plants and 5 recipes used in Thai folklore medicine at the concentration of 50 μg/ml Data are presented as mean ± SD from 3 independent experiments, triplicate for each) Cytotoxicity of 5-FU and ethanolic extracts from 5 medicinal plants and one recipe with promising activity Data are presented otherwise specified as mean ± SD of IC50 (μg/ml) from 3 independent experiments, triplicate for each. Investigation of comparative cytotoxic activities of the extracts of the six plants and the standard drug 5-FU against CL-6, HepG-2 Hep-2 and HRE cell lines indicate difference in responsiveness/sensitivity of different cancerous cells to these plant extracts (Table 3 and Figure 1). The results were generally in agreement with that shown in the screening test, confirming that Hep-2 was the most sensitive, while HepG2 was the most resistant cell line to the tested ethanolic extracts from Thai traditional folklore. All extracts possessed high activity against Hep-2 cell with mean IC50 values ranging from 18.93 to 32.40 μg/ml. In contrast, activity against the hepatoma cell HepG2 varied markedly with mean IC50 values ranging from 9.67 to 115.47 μg/ml. The only promising extract was from Zingiber officinal (IC50 = 9.67 ± 3.91 μg/ml). The extract from Atractylodes lancea exhibited the most potent activity against CL-6 but the activities against the other two cancerous cells were only moderate. The extract from Zingiber officinal was most promising against HepG2 cell line, whereas that from Piper chaba was most promising against Hep-2 cell. This may suggest that HepG2 is the most resistant among the three cancerous cell lines under investigation. Only two crude extracts from Curcuma longa and Mammea siamensis showed high activity against HepG2 cell. Crude extracts from Curcuma longa exhibited high activity against both HepG2 and Hep-2 (% survival of 13.9 and 0.6, respectively) but relatively low activity against CL-6 cell line (% survival of 59.9). The ethanolic extract of Mammea siamensis showed promising activity against only HepG2 cell (29.2%) with relatively low activity against CL-6 and Hep-2 cell line with % survival of 51.4 and 59.5, respectively (Table 2). Selectivity of the cytotoxic activity of the six tested extracts was determined by comparing the cytotoxic activity (IC50) of each plant extract against each cancerous cell with that of the normal human cell HRE (Table 3). Results were expressed as selectivity index (SI). SI of greater than 3 was considered as highly selective. The extract from Atractylodes lancea appears to be both the most potent and most selective against cholangiocarcinoma (IC50 = 24.09 ± 3.40 μg/ml, SI 8.6), whereas that from Zingiber officinal appears to be the most potent and most selective against HepG2 (IC50 = 9.67 ± 3.91 μg/ml, SI = 12.6). For Hep-2 cell, Piper chaba (IC50 = 18.63 ± 5.03 μg/ml, SI = 9.8) and Pra-Sa-Prao-Yhai recipe (IC50 = 20.99 ± 2.68 μg/ml, SI = 12.5) exhibited the most promising and most selective cytotoxic activity.
Figure 1

Mean IC: AL = Atractylodes lancea, KG = Kaempferia galangal, ZO = Zingiber officinal, PC = Piper chaba, PSPYR = Pra-Sa-Prao-Yhai recipe, MF = Mesua ferrea

Mean IC: AL = Atractylodes lancea, KG = Kaempferia galangal, ZO = Zingiber officinal, PC = Piper chaba, PSPYR = Pra-Sa-Prao-Yhai recipe, MF = Mesua ferrea Difference in responsiveness/sensitivity of different cancerous cells to different chemotherapeutics are commonly observed in various studies [11,12,17,18]. The responsiveness of all the four cells to 5-FU varied according to cell types, particularly with CL-6 cell (IC50 = 757 ± 72.16 μM). Although 5-FU is the standard chemotherapeutic drug used in the treatment of human cholangiocarcinoma, evidence of 5-FU resistance has been reported both in vitro [9] and in vivo [7]. It has been demonstrated in a previous study [19] that variations in the sensitivity to chemotherapeutic drugs were observed among the five intrahepatic cholangiocarcinoma cell lines and sensitivity to chemotherapeutic drug. Cholangiocarcinoma is a fatal disease which is highly resistant to anticancer drugs. It is noted that the IC50 values of 5-FU observed in the present study and the previous study [19] were much higher than those reported in other cancerous cell lines, e.g., colon carcinoma (HCC-48, COLO20) [20] and cervical squamous carcinoma (SiHa, HeLa) cell lines [21]. This suggests low sensitivity of cholangiocarcinoma to all chemotherapeutics including those obtained from medicinal plant source, which is probably due in part to enhanced resistance to apoptosis. Several genes involved in the apoptosis, detoxification and efflux processes have been reported to influence resistance to chemotherapeutic agents, for examples multidrug resistance protein (MDR1) and multidrug-resistance associated proteins (MRPs) [22], glutathione-S-transferase (GST) [23], dihydropyrimidine dehydrogenase (DPD) [24], and galectin-3 [25]. Active compound from Atractylodes lancea has been shown to exhibit strong inhibitory effects on 5-lipoxygenase (5-LOX) and cyclooxygenase-1 (COX-1), but exhibited only weak antioxidative activities [IC50 = 0.1 μM (5-LOX), 2 μM (COX-1), 9 μM (PMN/FMLP), 28 μM (PMN/OZ)] [26]. The alcoholic extracts of Kaempferia galangal showed high cytotoxicity against SW 620 with IC50 less than 30 μg/ml and showed moderate cytotoxicity against cancer cells DU145 (human prostate cancer cell line), PA1 (human ovarian teratocarcinoma cell line), and B16F10 (murine melanoma cells) and were not selective against cancer cells when compared to Vero cells [27]. In the case of Zingiber officinal methanolic extracts, cytotoxic activities against human A549 (adenocarcinomic alveolar basal epithelial cell line), SK-OV-3 (ovarian carcinoma cell line), SK-MEL-2 (skin Melanoma cell line), and HCT15 (colon carcinoma cell line) have been reported [28]. From the study of Sakpakdeejaroen et al., piperine, the active compound of Piper chaba, showed cytotoxic activity against MCF-7 (breast cancer cell line) with IC50 equal to 35.72 μM [29]. The active compounds of Mesua ferrea including phenylcoumarins, xanthones and triterpenoids were reported to possess cytotoxic and antibacterial activities [30].

Conclusions

Results obtained from this study indicate that 6 out of a total of 28 plants and 5 recipes (Atractylodes lancea, Kaempferia galangal, Zingiber officinal, Piper chaba, Mesua ferrea, and Pra-Sa-Prao-Yhai recipe) used in Thai folklore medicine exhibited promising cytotoxic activity against CL-6 human cholangiocarcinoma cell line. Sensitivity to other cancerous cell lines varied according to cell types and the hepatocarcinoma HepG2 appears to be the most resistant cell line to the tested extracts. The extract from Atractylodes lancea appears to be both the most potent and most selective against cholangiocarcinoma, whereas that from Zingiber officinal appears to be the most potent and most selective against HepG2. The extract from Piper chaba (IC50 = 18.63 μg/ml, SI = 9.8) and Pra-Sa-Prao-Yhai recipe (IC50 = 20.99 μg/ml, SI = 12.5.) exhibited the most promising and most selective cytotoxic activity against Hep-2 cell line. Further investigation of all the six extracts for their cytotoxic activity against cholangiocarcinoma in hamster model is underway to fully assess the anticancer activity in vivo.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

KN conceived and designed the study, reviewed and finalized the manuscript. WM performed the laboratory work, and drafted the manuscript. VV obtained the financial support for the project, reviewed and provided comments and suggestions to improve the quality of the manuscript. WC performed data analysis. AI prepared the medicinal plants and all the herbal extracts. All authors read and approved the final manuscript.

Pre-publication history

The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1472-6882/10/55/prepub
  23 in total

Review 1.  The role of chemotherapy in cholangiocarcinoma.

Authors:  S Thongprasert
Journal:  Ann Oncol       Date:  2005       Impact factor: 32.976

2.  Low-dose cisplatin and 5-fluorouracil in combination can repress increased gene expression of cellular resistance determinants to themselves.

Authors:  M Nishiyama; W Yamamoto; J S Park; R Okamoto; H Hanaoka; H Takano; N Saito; M Matsukawa; T Shirasaka; M Kurihara
Journal:  Clin Cancer Res       Date:  1999-09       Impact factor: 12.531

3.  Drug sensitivity and drug resistance profiles of human intrahepatic cholangiocarcinoma cell lines.

Authors:  Nisana Tepsiri; Liengchai Chaturat; Banchob Sripa; Wises Namwat; Sopit Wongkham; Vajarabhongsa Bhudhisawasdi; Wichittra Tassaneeyakul
Journal:  World J Gastroenterol       Date:  2005-05-14       Impact factor: 5.742

4.  Phase II trial of cisplatin, interferon alpha-2b, doxorubicin, and 5-fluorouracil for biliary tract cancer.

Authors:  Y Z Patt; M M Hassan; R D Lozano; K A Waugh; A M Hoque; A I Frome; S Lahoti; L Ellis; J N Vauthey; S A Curley; I I Schnirer; I Raijman
Journal:  Clin Cancer Res       Date:  2001-11       Impact factor: 12.531

5.  Functional study of intracellular P-gp- and MRP1-mediated pumping of free cytosolic pirarubicin into acidic organelles in intrinsic resistant SiHa cells.

Authors:  Ponpun Laochariyakul; Mathurose Ponglikitmongkol; Samlee Mankhetkorn
Journal:  Can J Physiol Pharmacol       Date:  2003-08       Impact factor: 2.273

Review 6.  Glutathione-associated enzymes in anticancer drug resistance.

Authors:  K D Tew
Journal:  Cancer Res       Date:  1994-08-15       Impact factor: 12.701

7.  Epirubicin, cisplatin, and protracted infusion of 5-FU (ECF) in advanced intrahepatic cholangiocarcinoma.

Authors:  Myung Ah Lee; In Sook Woo; Jin-Hyoung Kang; Young Seon Hong; Kyung Shik Lee
Journal:  J Cancer Res Clin Oncol       Date:  2004-02-28       Impact factor: 4.553

8.  In vitro cytotoxic activity of Thai medicinal plants used traditionally to treat cancer.

Authors:  Arunporn Itharat; Peter J Houghton; E Eno-Amooquaye; P J Burke; Julia H Sampson; Amala Raman
Journal:  J Ethnopharmacol       Date:  2004-01       Impact factor: 4.360

9.  Suppression of galectin-3 expression enhances apoptosis and chemosensitivity in liver fluke-associated cholangiocarcinoma.

Authors:  Sopit Wongkham; Mutita Junking; Chaisiri Wongkham; Banchob Sripa; Siri Chur-In; Norie Araki
Journal:  Cancer Sci       Date:  2009-09-01       Impact factor: 6.716

10.  Studies of the in vitro anticancer, antimicrobial and antioxidant potentials of selected Yemeni medicinal plants from the island Soqotra.

Authors:  Ramzi A Mothana; Ulrike Lindequist; Renate Gruenert; Patrick J Bednarski
Journal:  BMC Complement Altern Med       Date:  2009-03-25       Impact factor: 3.659

View more
  42 in total

1.  Anticancer mechanisms of Strobilanthes crispa Blume hexane extract on liver and breast cancer cell lines.

Authors:  Rhun Yian Koh; Foong Ping Lim; Leslie Siing Yie Ling; Catherine Pei Ling Ng; Siew Foong Liew; Mei Yeng Yew; Yee Lian Tiong; Anna Pick Kiong Ling; Soi Moi Chye; Khuen Yen Ng
Journal:  Oncol Lett       Date:  2017-08-24       Impact factor: 2.967

2.  Theobroma cacao: Review of the Extraction, Isolation, and Bioassay of Its Potential Anti-cancer Compounds.

Authors:  Zainal Baharum; Abdah Md Akim; Taufiq Yap Yun Hin; Roslida Abdul Hamid; Rosmin Kasran
Journal:  Trop Life Sci Res       Date:  2016-02

3.  Cytotoxic activity of anticancer drugs on hepatocellular carcinoma cells in hypoxic-hyponutritional culture.

Authors:  Qiang Li; Lin-Zhong Zhu; Ren-Jie Yang; Xu Zhu
Journal:  Int Surg       Date:  2014 Nov-Dec

4.  Identification of a 3,3-difluorinated tetrahydropyridinol compound as a novel antitumor agent for hepatocellular carcinoma acting via cell cycle arrest through disturbing CDK7-mediated phosphorylation of Cdc2.

Authors:  Wu Bi; Ji-Chang Xiao; Rui-Jie Liu; Liu-Ying Zhou; Sai Zhang; Mei Yang; Peng-Fei Zhang
Journal:  Invest New Drugs       Date:  2019-05-11       Impact factor: 3.850

5.  Ru(II)/diphenylphosphine/pyridine-6-thiolate complexes induce S-180 cell apoptosis through intrinsic mitochondrial pathway involving inhibition of Bcl-2 and p53/Bax activation.

Authors:  Wanessa Carvalho Pires; Benedicto Augusto Vieira Lima; Flávia de Castro Pereira; Aliny Pereira Lima; Francyelli Mello-Andrade; Hugo Delleon Silva; Monize Martins da Silva; Legna Colina-Vegas; Javier Ellena; Alzir A Batista; Elisângela de Paul Silveira-Lacerda
Journal:  Mol Cell Biochem       Date:  2017-08-09       Impact factor: 3.396

6.  Anticancer and antibacterial secondary metabolites from the endophytic fungus Penicillium sp. CAM64 against multi-drug resistant Gram-negative bacteria.

Authors:  Jean-Bosco Jouda; Jean-de-Dieu Tamokou; Céline Djama Mbazoa; Prodipta Sarkar; Prasanta Kumar Bag; Jean Wandji
Journal:  Afr Health Sci       Date:  2016-09       Impact factor: 0.927

7.  Cytotoxicity of methanol extracts of Elaeis guineensis on MCF-7 and Vero cell lines.

Authors:  Soundararajan Vijayarathna; Sreenivasan Sasidharan
Journal:  Asian Pac J Trop Biomed       Date:  2012-10

8.  Development and application of DNA markers to detect adulteration with Scopolia japonica in the medicinal herb Atractylodes lancea.

Authors:  Su Hong Oh; Yea Dam Kim; Cheol Seong Jang
Journal:  Food Sci Biotechnol       Date:  2021-11-26       Impact factor: 2.391

9.  Anti-proliferative effects of Salacia reticulata leaves hot-water extract on interleukin-1β-activated cells derived from the synovium of rheumatoid arthritis model mice.

Authors:  Yuusuke Sekiguchi; Hiroshi Mano; Sachie Nakatani; Jun Shimizu; Kenji Kobata; Masahiro Wada
Journal:  BMC Res Notes       Date:  2012-04-26

10.  Anticancer activities against cholangiocarcinoma, toxicity and pharmacological activities of Thai medicinal plants in animal models.

Authors:  Tullayakorn Plengsuriyakarn; Vithoon Viyanant; Veerachai Eursitthichai; Porntipa Picha; Piengchai Kupradinun; Arunporn Itharat; Kesara Na-Bangchang
Journal:  BMC Complement Altern Med       Date:  2012-03-27       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.